US Patent

US10058614 — Pharmaceutical compositions comprising meloxicam

Formulation · Assigned to Axsome Therapeutics Inc · Expires 2036-04-11 · 10y remaining

Vulnerability score 43/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects pharmaceutical compositions that combine meloxicam with cyclodextrin and/or a carbonate or bicarbonate for oral administration.

USPTO Abstract

Disclosed herein are compositions comprising an NSAID such as meloxicam in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of conditions such as pain.

Drugs covered by this patent

Patent Metadata

Patent number
US10058614
Jurisdiction
US
Classification
Formulation
Expires
2036-04-11
Drug substance claim
No
Drug product claim
Yes
Assignee
Axsome Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.